Skip Navigation



Annals of Oncology Advance Access published online on April 22, 2005
Annals of Oncology, doi:10.1093/annonc/mdi206
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/7/1207    most recent
mdi206v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sanna, G.
Right arrow Articles by Goldhirsch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanna, G.
Right arrow Articles by Goldhirsch, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter

Jaw avascular bone necrosis associated with long-term use of biphosphonates

G. Sanna 1*, M. G. Zampino 1, G. Pelosi 1, F. Nolè 1, and A. Goldhirsch 1

1 Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy

* To whom correspondence should be addressed.
G. Sanna, E-mail: giuseppina.sanna{at}ieo.it



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Journal of RheumatologyHome page
A. A. KHAN, G. K.B. SANDOR, E. DORE, A. D. MORRISON, M. ALSAHLI, F. AMIN, E. PETERS, D. A. HANLEY, S. R. CHAUDRY, B. LENTLE, et al.
Bisphosphonate Associated Osteonecrosis of the Jaw
J Rheumatol, March 1, 2009; 36(3): 478 - 490.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
C. D Krueger, P. M West, M. Sargent, A. E Lodolce, and A S. Pickard
Bisphosphonate-Induced Osteonecrosis of the Jaw
Ann. Pharmacother., February 1, 2007; 41(2): 276 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G Sanna, L Preda, R Bruschini, M Cossu Rocca, S Ferretti, L Adamoli, E Verri, L Franceschelli, A Goldhirsch, and F Nole
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer
Ann. Onc., October 1, 2006; 17(10): 1512 - 1516.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
T. Van den Wyngaert, M. T. Huizing, and J. B. Vermorken
Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?
Ann. Onc., August 1, 2006; 17(8): 1197 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M. Ardine, D. Generali, M. Donadio, S. Bonardi, M. Scoletta, A. M. Vandone, M. Mozzati, O. Bertetto, A. Bottini, L. Dogliotti, et al.
Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?
Ann. Onc., August 1, 2006; 17(8): 1336 - 1337.
[Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
D. Kademani, S. Koka, M. Q. Lacy, and S. V. Rajkumar
Primary Surgical Therapy for Osteonecrosis of the Jaw Secondary to Bisphosphonate Therapy
Mayo Clin. Proc., August 1, 2006; 81(8): 1100 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. Errante, N. Mannucci, D. Bernardi, A. Bianco, and L. Salvagno
Comment on 'Jaw avascular bone necrosis associated with long-term use of biphosphonates'
Ann. Onc., February 1, 2006; 17(2): 350 - 352.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.